So, TF is paying us to make APAS Pharma work on TF media. Control the device and consumables.
In parallel, a multinational pharmaceutical company (I'm going to assume BigPharma) wants us on their own project.
BioPhorum doesn't get a mention here.
On 14th September this year, LBT reported on their presentation to BioPhorum's Alternative & Rapid Microbiology Methods working group and the successful proof-of-concept. It appears to me that BigPharma has taken on the next stage of the APAS Pharma project on a go-alone basis. However the intel from a successful partnership with LBT would be shared with the BioPhorum membership. The collaboration of multinational pharmaceutical companies that make up BioPhorum control approximately 60% of the global market. Most of that is in the US, of course.
So is BigPharma/BioPhorum doing the regulatories with LBT to then, if successful, hand the shelf-ready Modules to Thermo Fisher to sell to them?
What else would a MNC pharmaceutical want out of APAS Pharma?
GLTAH
- Forums
- ASX - By Stock
- Ann: LBT Strengthens APAS Pharma Development
So, TF is paying us to make APAS Pharma work on TF media....
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LBT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.6¢ |
Change
0.001(3.23%) |
Mkt cap ! $27.98M |
Open | High | Low | Value | Volume |
1.6¢ | 1.6¢ | 1.6¢ | $31.62K | 1.976M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1847724 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 1063750 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1847724 | 0.015 |
4 | 1001428 | 0.014 |
2 | 6718666 | 0.012 |
2 | 78500 | 0.011 |
4 | 1949004 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 1063750 | 2 |
0.017 | 1732416 | 4 |
0.018 | 1604121 | 9 |
0.019 | 1316951 | 8 |
0.020 | 1685548 | 5 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
LBT (ASX) Chart |